Document is current

Any future updates will be listed below

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

Crossref DOI link: https://doi.org/10.1136/lupus-2021-000584

Published Online: 2022-05-31

Published Print: 2022-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark